Response to neoadjuvant chemotherapy in breast cancer: do microRNAs matter?

Abstract

Background Conventionally, breast cancer (BC) prognosis and prediction of response to therapy are based on TNM staging, histological and molecular subtype, as well as genetic alterations. The role of various epigenetic factors has been elucidated in carcinogenesis. However, it is still unknown to what extent miRNAs affect the response to neoadjuvant chemotherapy (NACT). This pilot study is focused on evaluating the role of miR-34a, miR-124a, miR-155, miR-137 and miR-373 in response to NACT. Methods That was a prospective study enrolling 34 patients with histologically confirmed BC of II-III stages. The median age of patients was 53 (47–59.8) years old, 70.6% of whom were HR-positive. MiRs levels were measured in the primary tumor before and after NACT. The response to therapy was assessed after surgery using the Miller-Payne scoring system. To establish the role of miRs in modulating response to NACT the Cox model was applied for analysis. Results BC demonstrated a great variability of miRs expression before and after NACT with no strong links to tumor stage and molecular subtype. Only miR-124a and miR-373 demonstrated differential expression between malignant and normal breast tissues before and after therapy though these distinctions did not impact response to NACT. Besides miR-124a and miR-137 levels after NACT were found to be dependent on HR status. While miR-124a levels increased (p = 0.021) in the tumor tissue, the expression of miR-137 was downregulated (p = 0.041) after NACT in HR positive BC. Conclusions The study revealed differences in miR-124a and miR-373 expression after NACT in primary BC tissues. Although miRs levels did not impact the response to NACT, we found miR-124a and miR-137 levels to be related to hormonal sensitivity of BC.

Investigating the role of tumour-to-skin proximity in predicting nodal metastasis in breast cancer

“…R core packages were used for statistical analysis (R Core Team (2022)). Pearson test χ 2 (for qualitative variables) and T-Wilcoxon test for paired samples (for quantitative variables) were applied to compare individual tumour characteristics between node-positive and node-negative tumour groups [ 9 , 14 ]. Logistic regression analysis investigated the relationship between TSD and other tumour variables significant on univariate analysis.…”

The Emerging Roles of Exosomal miRNAs in Breast Cancer Progression and Potential Clinical Applications

“…Aberrant miRNA and exosomal miRNA expression levels in the serum of BC patients are intensively implicated in resistance to multiple therapeutic agents for BC. 90,91 In immunotherapy, anti-PD-1 treatment promoted the expression of lymphocyte-derived exosomal miRNA-4315 and suppressed BIM-mediated tumor apoptosis, endowing the potential of exosomal miRNA-4315 in blood as patient stratification for anti-PD-1 treatment. 92 Exosome-shuttled miR-567 restrained the trastuzumab resistance, and could be internalized by recipient BC cells to enhance the curative effect of chemotherapy by inhibiting ATG5 in BC.…”

Potential Impact of Preoperative Circulating Biomarkers on Individual Escalating/de-Escalating Strategies in Early Breast Cancer

“…More and more ncRNA have been cataloged and connected to the prediction of treatment response in eBC [183][184][185]. However, low sensitivity and low specificity of detection techniques limit miRNA analysis, and new methods are under development.…”